SG11202109835WA - Methods for predicting prostate cancer and uses thereof - Google Patents
Methods for predicting prostate cancer and uses thereofInfo
- Publication number
- SG11202109835WA SG11202109835WA SG11202109835WA SG11202109835WA SG 11202109835W A SG11202109835W A SG 11202109835WA SG 11202109835W A SG11202109835W A SG 11202109835WA SG 11202109835W A SG11202109835W A SG 11202109835WA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- prostate cancer
- predicting prostate
- predicting
- cancer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Data Mining & Analysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Databases & Information Systems (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Artificial Intelligence (AREA)
- Physiology (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Evolutionary Computation (AREA)
- Software Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819325P | 2019-03-15 | 2019-03-15 | |
| US202062978184P | 2020-02-18 | 2020-02-18 | |
| PCT/US2020/022862 WO2020190819A1 (en) | 2019-03-15 | 2020-03-14 | Methods for predicting prostate cancer and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202109835WA true SG11202109835WA (en) | 2021-10-28 |
Family
ID=72424177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202109835W SG11202109835WA (en) | 2019-03-15 | 2020-03-14 | Methods for predicting prostate cancer and uses thereof |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11661633B2 (zh) |
| EP (1) | EP3938052A4 (zh) |
| JP (1) | JP2022524382A (zh) |
| KR (1) | KR20210141949A (zh) |
| CN (1) | CN113614249A (zh) |
| AU (1) | AU2020241720A1 (zh) |
| CA (1) | CA3133294A1 (zh) |
| CL (1) | CL2021002387A1 (zh) |
| SG (1) | SG11202109835WA (zh) |
| WO (1) | WO2020190819A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112530581B (zh) * | 2020-12-03 | 2023-11-21 | 安徽医科大学第一附属医院 | 一种前列腺癌患者的免疫分子分类系统及其应用 |
| CN114908160A (zh) * | 2021-02-08 | 2022-08-16 | 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） | Snord60作为子宫内膜癌诊断的标志物及其应用 |
| WO2023172535A2 (en) * | 2022-03-07 | 2023-09-14 | University Of Connecticut | shRNA TARGETING SNORD115 LOCATIONS TO RESTORE PATERNAL UBE3A GENE EXPRESSION IN ANGELMAN SYNDROME |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2142659A4 (en) * | 2007-04-30 | 2010-06-09 | Univ Ohio State Res Found | METHOD FOR THE DISTINCTION OF PANCREATIC CANCER OF NORMAL IMMERSION SPECTRUM FUNCTIONS AND CHRONIC IMMERSION IMAGING IGNITION |
| EP2634266B1 (en) | 2009-05-22 | 2015-10-14 | Asuragen, INC. | miRNA biomarkers of prostate disease |
| EP2341145A1 (en) * | 2009-12-30 | 2011-07-06 | febit holding GmbH | miRNA fingerprint in the diagnosis of diseases |
| WO2014085906A1 (en) | 2012-12-03 | 2014-06-12 | St. Michael's Hospital | Microrna biomarkers for prostate cancer |
| US20170356903A1 (en) * | 2014-11-21 | 2017-12-14 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| ES2749651T3 (es) | 2015-02-11 | 2020-03-23 | Region Midtjylland | Método basado en microARN para la detección temprana de cáncer de próstata en muestras de orina |
| US20190144951A1 (en) | 2016-06-08 | 2019-05-16 | Mir Scientific, Llc | Methods and compositions for prostate cancer diagnosis and treatment |
-
2020
- 2020-03-14 WO PCT/US2020/022862 patent/WO2020190819A1/en active Application Filing
- 2020-03-14 CA CA3133294A patent/CA3133294A1/en active Pending
- 2020-03-14 EP EP20774336.0A patent/EP3938052A4/en active Pending
- 2020-03-14 JP JP2021553304A patent/JP2022524382A/ja active Pending
- 2020-03-14 US US16/819,070 patent/US11661633B2/en active Active
- 2020-03-14 CN CN202080021149.1A patent/CN113614249A/zh active Pending
- 2020-03-14 SG SG11202109835W patent/SG11202109835WA/en unknown
- 2020-03-14 KR KR1020217031415A patent/KR20210141949A/ko active Search and Examination
- 2020-03-14 AU AU2020241720A patent/AU2020241720A1/en active Pending
-
2021
- 2021-09-13 CL CL2021002387A patent/CL2021002387A1/es unknown
-
2023
- 2023-04-24 US US18/138,207 patent/US20230257826A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113614249A (zh) | 2021-11-05 |
| AU2020241720A1 (en) | 2021-10-14 |
| US11661633B2 (en) | 2023-05-30 |
| JP2022524382A (ja) | 2022-05-02 |
| EP3938052A4 (en) | 2022-12-21 |
| US20200291485A1 (en) | 2020-09-17 |
| EP3938052A1 (en) | 2022-01-19 |
| CA3133294A1 (en) | 2020-09-24 |
| WO2020190819A1 (en) | 2020-09-24 |
| KR20210141949A (ko) | 2021-11-23 |
| CL2021002387A1 (es) | 2022-06-17 |
| US20230257826A1 (en) | 2023-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3891294A4 (en) | METHODS OF TREATMENT FOR CASTRATION-RESISTANT AND CASTRATION-SENSITIVE PROSTATE CANCER | |
| IL288182A (en) | Systems and methods for estimating growth fraction | |
| EP3594365A4 (en) | HER2-POSITIVE CANCER BIOMARKER AND ANTI-HER2 TREATMENT AND ITS USE | |
| SG11202101397TA (en) | Biomarkers for cancer therapy | |
| IL284561A (en) | Neoantigens of the prostate and their uses | |
| SG11202109835WA (en) | Methods for predicting prostate cancer and uses thereof | |
| EP3565560A4 (en) | PREDICTIVE AND DIAGNOSTIC PROCEDURES FOR PROSTATE CANCER | |
| GB201806064D0 (en) | Improved Classification And Prognosis Of Prostate Cancer | |
| RS62972B1 (sr) | Mrnk markeri na bazi pune krvi za predviđivanje raka prostate i metode otkrivanja istog | |
| EP3691536A4 (en) | APPARATUS AND METHOD FOR DETERMINING THE SPATIAL PROBABILITY OF PROSTATE CANCER | |
| EP3778592A4 (en) | RADIOPHARMIC AGAINST PSMA FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | |
| GB201905111D0 (en) | Novel biomarkers and diagnostic profiles for prostate cancer | |
| EP3468564A4 (en) | METHOD FOR DIAGNOSTICING AND TREATING METASTASIVE CANCER | |
| EP3830134A4 (en) | COMPOSITIONS AND METHODS FOR DETECTING PROSTATE CANCER | |
| GB201915464D0 (en) | Novel biomarkers and diagnostic profiles for prostate cancer | |
| GB201915469D0 (en) | Cancer detection methods | |
| GB2594103B (en) | Prostate cancer biomarkers | |
| EP3405583A4 (en) | COMPOSITIONS AND METHODS FOR SCREENING AND IDENTIFYING CLINICALLY AGGRESSIVE PROSTATE CANCER | |
| EP3675893A4 (en) | METHOD OF TREATMENT AND DIAGNOSIS OF METASTATIC LIVER CANCER | |
| EP3835434A4 (en) | PROSTATE CANCER DETECTION KIT, DEVICE AND METHOD | |
| EP3332037A4 (en) | METHODS FOR PREDICTING PROSTATE CANCER RECHUTE | |
| GB201703640D0 (en) | Prostate cancer biomarkers | |
| AU2019902054A0 (en) | Prostate cancer detection | |
| EP3606536A4 (en) | INDICATIVE BIOMARKERS OF PROSTATE CANCER AND RELATED TREATMENT | |
| GB201909135D0 (en) | Means and methods for treating cancer |